Only two days remain to take advantage of early bird registration for RECON 2025! 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐭𝐨𝐝𝐚𝐲!🎉 ➡ https://lnkd.in/gE6WZtuj Why attend? 1. Discover cutting-edge internal and external R&D intelligence techniques driving successful drug development. 2. Learn from real-world examples of transformative industry breakthroughs. 3. Connect with like-minded professionals, expand your network, and engage in meaningful discussions. 🔎 Explore the Agenda: https://lnkd.in/girYwv7j Our speaker lineup includes luminaries from the FDA, industry leaders, and academia. Over the course of the two-day conference, we will delve into: 1. 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐭𝐨 𝐄𝐧𝐝𝐩𝐨𝐢𝐧𝐭 𝐓𝐫𝐚𝐧𝐬𝐥𝐚𝐭𝐢𝐨𝐧 - Establishing surrogate endpoints. 2. 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐇𝐚𝐫𝐦𝐨𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧 - Towards a streamlined global regulatory assessment. 3. 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐎𝐩𝐭𝐢𝐦𝐮𝐬 - R&D strategies, practicality, and collaboration between FDA and sponsors. 4. 𝐃𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐢𝐧 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 - Strategies and implications for enhancing clinical trial diversity. Spread the word among your colleagues- we can't wait to welcome you all there! #RECON #UniversityOfMarylandBaltimore #DrugDevelopment #Pharma #BioTech #FDA #ProjectOptimus #ClinicalTrials #RegulatoryStrategy #Biomarkers #Endpoints #RegulatoryHarmonization #VivproCorp #MorePowerToYou
Vivpro Corp’s Post
More Relevant Posts
-
At Divergent, we believe that clinical research is more than just a process - it's a journey of discovery driven by a deep commitment to patient well-being and a relentless pursuit of innovation. So, as a leading clinical research organization (CRO), we approach each challenge with a unique blend of disciplined expertise and intuitive understanding. Listening and understanding form the foundation of our approach. We take the time to deeply engage with our clients, partners, and the patients we serve, making sure that we have a comprehensive grasp of their needs, concerns, and aspirations. This understanding allows us to navigate the complexities of clinical trials with unparalleled precision, anticipating and addressing obstacles before they can impede progress. To learn more about us, visit divergentcro.com #pharma #research #biotech #medical #monitoring #qualityassurance #quality #drug
To view or add a comment, sign in
-
Join our COO, Chris Schoonmaker and me at the Spring MIT Forum (June 17, 2024) for an exciting panel discussion on regulatory approvals and many other discussions. The conference brings together leaders in our field for a productive 2-day in-person dialogue on several key topics. Approvals are the grand finale of the work we do and I wake up every day with renewed energy to support yet another drug/biologic/therapeutic option for patients globally. At #OneMMS, this is our passion and expertise, working with regulators and sponsors to enhance efficiencies one submission at a time while maintaining our data-focused efforts. #dataCRO #biometrics #submissions
We are thrilled to announce that our CEO, Uma Sharma, will be moderating an insightful session on “Getting to Regulatory Approval” at the Longwood Healthcare Leaders Spring MIT Forum, June 17, 2024. With over 8-10 successful submissions each year over the past 17 years, MMS is the leading data and regulatory-focused CRO, with the know-how, technology, and track record of success guiding sponsors through their data services and clinical trial submission goals. Don’t miss the interactive panel discussion with the top minds in pharma, biotech, government, academia, and healthcare, where we will discuss biomedical innovations and the advancement of life-changing therapies to positively improve lives worldwide. Connect with Uma Sharma and Chris Schoonmaker (COO, MMS Holdings) at this event to explore how MMS can support your clinical data and regulatory submission needs from INDs to NDAs/BLAs. #Pharma #Biotech #OneMMS #HealthcareInnovation
To view or add a comment, sign in
-
Thank you to everyone who participated in our recent poll! The insights reveal that optimizing trial timelines is a key challenge for many of you, alongside identifying qualified investigators, ensuring diverse patient pools, and navigating regulations. At Chryselys, we're always looking for ways to streamline these complex processes. We believe there's always a smarter way to work, especially when it comes to clinical trials. Stay tuned for some exciting solutions that can simplify these processes and make your clinical trials more efficient. #Chryselys #ClinicalTrials #ResearchInnovation #Pharma #HealthcareSolutions #InnovationsInPharma #InvestigatorChallenges #InvestigatorTargeting
To view or add a comment, sign in
-
It’s in harmony and collaboration that exceptional results take shape! Join us for an exclusive webinar where we explore how a strong collaboration and partnership between vendors can change clinical trials, streamline processes, and achieve remarkable outcomes. Don't miss insights from Stephane Petit, Henk Dieteren, and Amaury Jeandrain, as they will share concrete examples of success. A source of inspiration for sponsors and CROs! Register now to secure your spot in this joint webinar with Clinigen, Suvoda, and N-SIDE Life Sciences 👉 https://lnkd.in/eyWW74fa #clinicaltrials #clinicalsupply #pharma #lifesciences #IT
To view or add a comment, sign in
-
🌟 From preclinical to post-market: Veristat delivers excellence at every phase. Whether it’s overcoming hurdles in the preclinical phase, navigating the complexities of clinical research, or ensuring smooth regulatory submissions and post-marketing support, Veristat is your trusted partner for full-service clinical research. 💬 Don’t just take our word for it: "I am grateful for the dedication, excitement, and clinical trial expertise that the Veristat team provided for our program. Veristat's collaboration was critical to the successful clinical trials that led to our product's approval." – President of Research and Development, Mid-size Pharma 👉 Swipe below to learn how we ensure your program's success at every step. #ClinicalResearch #DrugDevelopment #HealthcareInnovation #ClinicalTrialManagement #PatientSafety #Veristat
To view or add a comment, sign in
-
Pharma companies are using lab data to reach patients faster and more effectively. https://ow.ly/6VBc50Um84h. Dr. Madeline Naylor, DHSc, MSc, ACRP-CP, Vice President of Health Informatics, RWD at Norstella, writes about how lab data is being used across the product lifecycle, from drug development to patient monitoring. Learn how NorstellaLinQ fills in the gaps associated with typical real-world data assets, enabling a 360-degree view of the patient journey. Click the link in this post to read the article. #Pipeline2Patient #FollowNorstella #Pharma #LabData #PatientJourney #ClinicalResearch
To view or add a comment, sign in
-
Diversity in Clinical Trials. The FDA’s Diversity Action Plan (DAP) guidelines are a step toward more inclusive, representative clinical trials. By addressing recruitment barriers, building community trust, and engaging diverse populations, sponsors can generate more meaningful data and deliver equitable healthcare outcomes. At ACORN IQ, we help Pharma, Biotech, and CROs design DAP strategies, audits, culturally sensitive outreach-targeting, and continuous measurement. Contact us to learn how we can support your goals! #DiversityInResearch #ClinicalTrials #InclusionMatters #ACORNIQ #PatientEngagement #FDA #Pharma #Biotech #CEN Connect with us today: info@acorniq.co
To view or add a comment, sign in
-
In clinical research, success starts long before the first patient is enrolled. Early-stage planning is the foundation that can make or break a clinical trial. At Veristat, we understand that effective planning is key to overcoming the complexities of clinical trials. Our comprehensive services - from early-stage planning and patient recruitments to data management or regulatory support - ensure that every aspect of your trial is meticulously planned, setting the stage for long-term success. Swipe to see why early-stage planning matters 👉 You can learn more here: https://lnkd.in/eMYUj_FR #ClinicalTrials #ClinicalResearch #EarlyStagePlanning #Pharma #Biotech #Veristat #SuccessPlanning
To view or add a comment, sign in
-
Explore the Financial Impact of Delays in Drug Development at the 23rd Annual #ContractPharmaConference! On Day 1, join Zachary Smith from Tufts Center for the Study of Drug Development for Session 4 as he discusses the "Cost of a Day of Delay in Drug Development." Gain valuable insights into how even a single day can affect timelines and budgets in this critical area. Don't miss this important session that could help your business save time and money. Register today: https://hubs.li/Q02NCHvX0
To view or add a comment, sign in
-
Pharma companies are using lab data to reach patients faster and more effectively. https://ow.ly/jcYH50Um84w. Dr. Madeline Naylor, DHSc, MSc, ACRP-CP, Vice President of Health Informatics, RWD at Norstella, writes about how lab data is being used across the product lifecycle, from drug development to patient monitoring. Learn how NorstellaLinQ fills in the gaps associated with typical real-world data assets, enabling a 360-degree view of the patient journey. Click the link in this post to read the article. #Pipeline2Patient #FollowNorstella #Pharma #LabData #PatientJourney #ClinicalResearch
To view or add a comment, sign in
3,488 followers